Next Article in Journal
Characterization and Expression Analysis of Genes from Megalobrama amblycephala Encoding Hemoglobins with Extracellular Microbicidal Activity
Previous Article in Journal
Differentiation of Morphological Traits and Genome-Wide Expression Patterns between Rice Subspecies Indica and Japonica
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Genes
Volume 14
Issue 10
10.3390/genes14101973
genes-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Sequence Analysis of the Malaysian Low Pathogenic Avian Influenza Virus Strain H5N2 from Duck

by
Fatin Ahmad Rizal
1,
Kok Lian Ho
2,
Abdul Rahman Omar
1,3,
Wen Siang Tan
4,
Abdul Razak Mariatulqabtiah
1,5,* and
Munir Iqbal
6,*
1
Laboratory of Vaccine and Biomolecules, Institute of Bioscience, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia
2
Department of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia
3
Department of Veterinary Pathology and Microbiology, Faculty of Veterinary Medicine, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia
4
Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia
5
Department of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia
6
Avian Influenza and Newcastle Disease Group, The Pirbright Institute, Woking GU24 0NF, UK
*
Authors to whom correspondence should be addressed.
Genes 2023, 14(10), 1973; https://doi.org/10.3390/genes14101973
Submission received: 27 September 2023 / Revised: 19 October 2023 / Accepted: 21 October 2023 / Published: 22 October 2023
(This article belongs to the Section Microbial Genetics and Genomics)
Browse Figure
Review Reports Versions Notes

Abstract

:
The avian influenza viruses (AIV) of the H5 subtype have the ability to mutate from low pathogenic (LPAI) to highly pathogenic (HPAI), which can cause high mortality in poultry. Little is known about the pathogenic switching apart from the mutations at the haemagglutinin cleavage site, which significantly contributes to the virus virulence switching phenomenon. Therefore, this study aimed to compare the molecular markers in the haemagglutinin (HA), neuraminidase (NA), and matrix (M) genes of a locally isolated LPAI AIV strain H5N2 from Malaysia with the reference HPAI strains using bioinformatics approaches, emphasising the pathogenic properties of the viral genes. First, the H5N2 strain A/Duck/Malaysia/8443/2004 was propagated in SPF eggs. The viral presence was verified by haemagglutination assay, RT-PCR, and sequencing. Results showed successful amplifications of HA (1695 bp), NA (1410 bp), and M (1019 bp) genes. The genes were sequenced and the deduced amino acid sequences were analysed computationally using MEGA 11 and NetNGlyc software. Analysis of the HA protein showed the absence of the polybasic cleavage motif, but presence of two amino acid residues that are known to affect pathogenicity. There were also two glycosylation sites (glycosites) compared to the reference HPAI viruses, which had three or more at the HA globular head domain. No NA stalk deletion was detected but the haemadsorbing and active centres of the studied NA protein were relatively similar to the reference HPAI H5N2 isolates of duck but not chicken origins. Six NA glycosites were also identified. Finally, we observed a consistent M1 and M2 amino acid sequences between our LPAI isolate with the other HPAI H5N1 or H5N2 reference proteins. These data demonstrate distinct characteristics of the Malaysian LPAI H5N2, compared to HPAI H5N2 or H5N1 from ducks or chickens, potentially aiding the epidemiological research on genetic dynamics of circulating AIV in poultry.

1. Introduction

Avian influenza viruses (AIV) are composed of antisense, single stranded, and segmented RNA, and belong to the Orthomyxoviridae family. The virus genome is approximately 13.5 kb in length and contains eight segmented genes, i.e., haemagglutinin (HA), neuraminidase (NA), polymerase base subunits one and two (PB1 and PB2), polymerase acidic (PA), nucleoprotein (NP), matrix proteins (M), and non-structural proteins (NS), which encode ten or eleven proteins, depending on the virus strain [1]. The combination of the surface glycoproteins HA and NA determines the subtypes of influenza A viruses, each of which contains 18 (H1–H18) and 11 (N1–N11) antigens [2]. Apart from the HA-NA subtyping, AIV can be classified according to their ability to cause illness and death in chickens, i.e., low pathogenicity AIV (LPAIV) is generally known to cause no apparent or very moderate clinical disease, such as decreased egg production or ruffled feathers, while high pathogenicity AIV (HPAIV) can cause severe and fatal disease by damaging visceral organs and typically results in up to 100% mortality of chickens by day three [3]. All known HPAIV strains are of the H5 or H7 subtype. As evidenced by HPAI outbreaks in the US (1983–1984) and Mexico (1994), LPAI virus strain H5N2 has the propensity to mutate into HPAI viruses. Although the exact mechanisms underlying this pathotype change are somewhat unclear, several lines of evidence suggest that this is due to the recombination that typically occurred between the HA gene and NP genes, leading to the insertion of additional amino acids at the HA cleavage site. These conformational changes make the site more accessible to ubiquitous proteases such as furin and plasmin, and hence activate the virulence of the virus [4]. Multiple other independent LPAIV to HPAIV conversion events have been documented since 1959, when the first H5 HPAI virus was found in chicken farms in Scotland [5].
Different HPAI H5Nx (x = N1 − N9) strains cause variable disease severity in different bird species. Older HPAI H5 strains showed significant lethality in chickens, turkeys, and quails but not in ducks. However, with the emergence of the A/Goose/Guangdong/1/96 (Gs/Gd) lineage, H5N1 viruses can cause severe disease and mortality in several domestic and wild birds species, including ducks, geese, gulls, terns, shorebirds, and swans [6]. One of the main contributing factors is t differential binding affinity of different AIVs to the host cell surface receptors; the α-2,3- and α-2,6-sialic acid linked galactoses carry preferential binding avidity for avian or other species, respectively, and are widespread in several organs of both chickens and ducks. However, the chicken tracheal and intestinal epithelial cells express a broader range of sialic acid α-2,3-Gal receptors compared to ducks, which suggests that a wider range of avian type AIV can be sustained in chickens when compared to ducks [7]. Furthermore, ducks can initiate a rapid innate immune response due to rapid activation of major pattern recognition receptors, i.e., TLR7, RIG-I, and MDA-5, compared to chickens upon AIV infection [8]. Although chickens express MDA-5 receptors, the absence of RIG-I receptors, which are important in the recognition of viral RNA, mediates antiviral response and is postulated to cause delayed and inadequate inflammatory cytokine responses. Due to their intrinsic endurance against AIV, ducks may enhance the genetic reassortment of AIV strains, thus facilitating the generation of genetically diverse AIVs.
Malaysia’s first reported HPAI H5N1 outbreak in chickens occured in 2004 in Kelantan state. In the same year, LPAI H5N2 viruses were isolated from ducks in the Perak state [9]. Due to the more pressing factor to contain the severe effect of HPAI AIV, molecular, pathological, and vaccine research was focused more towards the circulating HPAIV H5N1 viruses, while the LPAI H5N2 isolates were used as the serological reference to perform the HA inhibition assays or indirect ELISA [10,11,12]. The LPAI H5N2 strain A/duck/Malaysia/8443/04 was developed as an inactivated whole-virus oil emulsion vaccine but was not effective against HPAI H5N1 strain A/chicken/Malaysia/5858/04 virus challenge in chickens [13]. Therefore, this study aimed to analyse the sequence of the Malaysian H5N2 strain in silico, emphasising the pathogenic properties of the viral genes. The data indicate that the Malaysian LPAI H5N2 isolate possesses a minimal threat in terms of pathogenicity due to the lack of HA cleavage, minimal identity to amino acids known to affect virulence, low number of potential glycosylation sites at the HA globular domain, and absence of the NA stalk deletion.

2. Materials and Methods

The LPAI H5N2 virus strain A/Malaysia/Duck/8443/04 (kindly provided by the Veterinary Research Institute (VRI) Ipoh, Perak) was propagated inside 11-days-old embryonated specific-pathogen-free (SPF) chicken eggs (Thai SPF Co. Ltd., Nakhon Nayok, Thailand). After 72 h of 37 °C incubation and 60% humidity, the eggs were chilled at 4 °C for 4 h. Then, the allantoic fluid was harvested, centrifuged (1000× g, 10 min, 4 °C), and subjected to HA assay. All wells except the first of a microtitre 96-well V-bottomed plate were filled with 50 µL of PBS (Life Technologies, Carlsbad, CA, USA). An aliquot (100 µL) of the virus sample was added to the first well. Then, 50 µL of the virus was diluted two folds across each well. Finally, each well was filled with 50 µL of 0.8% chicken red blood cells. The plate was then incubated for 30 min at room temperature. The plate was tilted 45 degrees to score the results, and the HA activity was verified by the forming of a tear-shaped stream. The virus titre was defined as the lowest virus concentration that caused complete agglutination of RBC and was denoted by the HA unit (HAU).
Viral RNA was extracted from the allantoic fluid using the PureLink Viral RNA/DNA Kit (Invitrogen, Carlsbad, CA, USA). Prior to the extraction, a carrier RNA/lysis buffer mixture provided in the kit was initially prepared. Then, 310 µL of RNAse-free water was added to 310 µg of lyophilised carrier RNA to make a stock of 1 µg/µL. The lysis buffer was added to the specified amount of carrier RNA stock in a fresh sterile tube, and the mixture was utilised within one hour. The subsequent viral extraction protocol was performed according to the manufacturer’s instructions without modifications.
Then, the RNAs were amplified using the SuperScript III one-step reverse transcriptase (RT)-PCR kit (Thermo Fisher Scientific, MA, USA). To begin, 25 µL of 2× reaction master mix, 10 µL of RNA template, 1.6 µM of each forward and reverse primers (Table 1), and 2 µL of platinum Taq High Fidelity Enzyme mix were added to a total reaction of 25 µL. The PCR protocol was 55 °C for 30 min (generation of cDNA), 94 °C for 2 min (pre-denaturation), followed by 40 cycles of 94 °C for 15 s (denaturation), 54 °C, 58 °C, or 60 °C (annealing, for M, NA and HA genes, respectively), and 68 °C for 1 min (extension). Final extension was conducted at 68 °C for 5 min. Positive amplicons were sent for Sanger sequencing (Apical Scientific Sdn Bhd, Selangor, Malaysia).
The full-length sequences of the isolated genes at the nucleotide and amino acid levels were aligned with closely related sequences obtained from the GenBank (NCBI, https://www.ncbi.nlm.nih.gov accessed on 25 September 2021) and Global Initiative for the Sharing All Influenza Data (GISAID, http://www.gisaid.org accessed on 25 September 2021) using MEGA software version 11 [16]. The quantity and distribution of N-glycosylation sites (glycosites) in HA and NA proteins were predicted using NetNGlyc software (https://services.healthtech.dtu.dk/service.php?NetNGlyc-1.0 accessed on 10 October 2022).

3. Results

3.1. Virus Isolation and Gene Amplications

The harvested virus stock showed a titration of 256 HA unit per 50 µL, which indicated the successful propagation of duck-originated AIV strain in the chicken embryos. Upon first round of RT-PCR on the extracted genomic viral RNA, only partial fragments of the HA, NA, and M genes were generated, i.e., 475 bp, 395 bp, and 726 bp, respectively. Therefore, a primer walking strategy using in-house oligoes was performed to generate the genes’ full-length sequences (Figure 1). The amplicons corresponded to the expected sizes for HA (1695 bp), NA (1410 bp), and M (1019 bp). These genes were deposited into the NCBI database with accession numbers ON714528 (HA), ON729981 (NA), and ON714539 (M).

3.2. Nucleotide Sequence Analysis

The full-length HA, NA, and M genes were subjected to BLAST to observe sequence similarity from the NCBI database (https://blast.ncbi.nlm.nih.gov/Blast.cgi accessed on 15 March 2022). The sequence was 99% matched to accession numbers DQ122147, DQ104702, and EU271940 for HA, NA, and M genes, respectively, from strain A/duck/Malaysia/F189/07/04(H5N2), which were deposited by the Agri-Food and Veterinary Authority of Singapore (AVA). Another strain with 98–99% sequence identity with those genes was the A/duck/Malaysia/F118/08/04(H5N2), which was isolated as part of Singapore’s routine surveillance for AIVs in avian species imported from Malaysia [17]. Other than these, the HA and NA sequences showed lower than 94% and 96% sequence identities, respectively, with other AIV strains such as the Mongolian AIV strain (A/duck/Mongolia/54/2001(H5N2). However, the M gene showed a 97% identity to a diverse HA subtypes, including H1, H3, H4, H6, H7, and H10, which suggests that the M gene is highly conserved across subtypes [18,19].

3.3. Amino acid Sequence Analysis

3.3.1. HA Protein

The pathogenicity of AIV can be indicated by the presence of a specific polybasic sequence site in which the ubiquitous subtilisin-like endoproteases, such as furin, will cleave the full length HA gene into HA1 and HA2 fragments to activate the severity of infections [20]. Table 2 shows a comparison of the cleavage motif of the studied HA gene compared with other HPAI and LPAI H5 reference genes. We observed that the studied HA cleavage motif was RETR, a motif that lacks the multibasic amino acid sequence and is consistent with other LPAI H5 subtypes, thus confirming the classification of our H5N2 virus sample as LPAI.
Amino acid residues of HA at positions 113, 124, 142, 154, 228, and 233 (numbering according to the first methionine residue) are known to affect the pathogenicity of HPAI viruses in chickens [21]. We performed an amino acid analysis of our LPAI HA based on this and observed an identical aspartic acid (D) at position 113 to all HPAI H5 subtype reference strains and an identical asparagine (N) at position 154 to the A/spotbill duck/Xuyi/18/2005(H5N2) strain (Table 3). Therefore, we suggest that the tendency of the studied virus to pose a threat as HPAI is low due to the minimal residue similarity. Furthermore, the identified amino acids are still relying on the rest of the HA amino acid and the balance of NA sequence contents to improve pathogenicity [22].
The N-linked glycosylation pattern of the HA gene was examined in which the subtypes of H5 viruses were subjected to N-glycosylation prediction. The results for the A/duck/Malaysia/8443/2004(H5N2) strain from this study showed 7 N-glycosylation locations, namely N26, N27, N39, N181, N302, N496, and N555. There are two glycosites on the globular domain and five glycosites on the stalk domain (Table 4). In the 1983 Pennsylvania outbreak-isolated H5N2 strain Chicken/Pennsylvania/1/83, the presence of site-specific glycosylation around the HA cleavage site and the effect of its internal genes is linked to virus virulence [23,24]. Meanwhile, the reference HPAI viruses showed additional glycosites at the globular head domain, which may associated with increased pathogenesis [25].

3.3.2. NA Protein

Neuraminidase activity can be influenced by the stalk length, haemadsorbing site, active centre, and the amount of glycosites. A deletion in the NA stalk was shown to favour the selection of H5 and H7 viruses with a polybasic cleavage site in the HA, thus increasing the pathogenic potentials [26]. In this study, no evidence of deletion in the stalk region of the studied and reference deduced NA amino acids of duck origins was observed as opposed to the HPAI H5N2 viruses from chicken hosts (deletions at positions 63–65) (Table 5). This may be among the contributing factors to the severity of AIV infection in chickens rather than ducks.
Analysis of sialic acid binding pockets within the haemadsorbing sites revealed the amino acid at positions 366–373, 399–404, and 431–433 [27] of the studied isolate were similar to the reference HPAI H5N2 isolate of duck but not chicken origins. Meanwhile, the active centres at positions 140–157 differ in three amino acids only [27,28]. The design of NA inhibitors should consider these conserved region of the NA haemadsorbing and active sites (Table 5).
NA glycosites with the N–X–T/S motif (in which X may be any amino acid except proline) were generated (Table 6). The result showed the NA protein of the studied and A/chicken/Hebei/1102-MA/2010 (H5N2) isolates contained six, while others contained seven to eight predicted glycosites. The H9N2 viruses of Eurasian ancestry share seven conserved potential NA glycosites [29]. It is suggested that the addition or deletion of glycosite increases virulence by modifying sialidase activity and triggering tissue tropism and antigenicity.

3.3.3. M Protein

The AIV matrix protein consists of the matrix 1 and 2 proteins (M1 and M2, respectively). Three amino acid alterations in M1, notably N30D, I43M, and T215A, increase the pathogenicity of A/H5N1 subtype AIVs in mice [30]. I43M increased virulence in chickens and ducks [30]. However, the underlying mechanisms for this increased virulence and pathogenicity remain unclear [31]. Our analysis showed these amino acids were consistent in the studied M1 gene with other H5N1 or H5N2 reference proteins (Table 7). Furthermore, the L26F, I/V27A/T/S, A30V/T/S, and G34E amino acids, which are known to contribute to adamantine resistance in M2 [32], were also identical across isolates. Adamantanes (amantadine and rimantadine) disrupt the early stages of virus propagation by blocking the M2 ion channel, thus resistance against the drug is a significant concern. A preventive strategy for the antiviral drug is via the use of vaccines. For example, the AIV vaccine based upon virus-like particles displaying the M2 ectodomain protein has been shown to offer a broad spectrum of immunogenicity [33,34].

4. Discussion

The natural reservoir of AIV is believed to be waterfowl belonging to the orders Anseriformes (ducks, geese, and swans) and Charadriiformes (gulls, terns, and sandpipers). LPAIV occasionally spreads from wild birds to domestic and aquatic fowl and are most likely transmitted from wild birds to poultry via direct or indirect interaction. Interestingly, HPAI or LPAI-infected wild ducks often do not exhibit clinical symptoms as opposed to poultry, hence the sequence comparison among the avian hosts continues to be relevant. In this study, we investigated the molecular sequence of a LPAI AIV strain H5N2 originated from a duck that was isolated in Malaysia within the same year of the country’s first HPAIV H5N1 outbreak in chicken. For sequence analysis, we excluded strains A/duck/Malaysia/F189/07/04(H5N2) and A/duck/Malaysia/F118/08/04(H5N2), which were deposited by the Agri-Food and Veterinary Authority of Singapore (AVA), since they shared 98–99% sequence identity to our studied HA, HA, and M genes. We referred our LPAI isolate of duck origin to the HPAI H5N2 and H5N1 isolates of duck and chicken origins to compare the pattern of amino acid changes, which would signify the genetic dynamics.
Several studies have reported the number of basic residues in the HA0 cleavage site, the mutation of key residues in the receptor binding domain, and the alteration of antigenic sites or N-glycosylation sites (glycosites) as among the factors that influence HA characteristics. HPAI viruses contain two or more consecutive basic amino acid (R or K), while the LPAI viruses contain a single or non-consecutive basic amino acid next to the cleavage site, which is only recognized by trypsin-like enzymes produced on epithelial cells. Removal of the pentabasic motif RRRKK from a HPAI HA H5 sequence from a Malaysian H5N1 isolate had been performed in AIV vaccine research to potentially reduce the biosafety concern [12].
AIVs acquire the ability to persist in target hosts by striking an active balance between attaching to the host and releasing progeny virions. To escape the host’s humoral and cellular immune systems, the potential glycosites in viral envelope proteins can provide identical glycans to those of the host’s cells to mask the antigenic sites. The influenza HA protein is highly glycosylated and the glycans on the HA may be recognized by cellular lectin receptors, enabling the virus to adhere to the cells and enable internalisation. Consequently, the degree of glycosylation of HA is probably crucial for identifying the virus by cellular lectins. Asparagine residues in the NXS/T motif (X can be any amino acid besides proline) are glycosylated through post-translational modification [35]. Numbers, types and locations of glycans vary from virus to virus, which may influence the lectin receptors’ ability to recognize AIVs. An increase in the number of N-glycosites on the globular head of HA H5 causes highly virulent avian influenza to escape from vaccine-induced immunity [36].
Beside the HA molecules, NA is essential for the reproduction and spread of the influenza virus, and NA gene alterations are strongly linked to antiviral medication resistance. NA is now well-known in regulating the pathogenicity or infectiousness of AIV in synergy with the HA. The biological function of the NA stalk is less known. Previous research has demonstrated that deletions in the NA stalk area affect the replication efficiency of AIV in vivo, extended its host range, decreased its NA enzymatic activity, and in some instances, improved its pathogenicity [37]. Stalk deleted NAs were reported sporadically in some AIV subtypes, e.g., H5N1, H6N1, H7N1, H7N3 and H9N2 [38]. This deletion is often accompanied by observations of variants on the HA protein, such as the addition of glycosites, presumably to maintain the functional balance between HA and NA, which is necessary for viral infectivity. These HA variations may have further effects on the antigenicity, virulence and pathogenicity of the virus.

5. Conclusions

Based on our findings, we concluded that the Malaysian-like LPAI H5N2 isolate poses a minimal threat in terms of pathogenicity due to the lack of HA cleavage, minimal identity to amino acids known to affect virulence, low number of glycosites at the HA globular domain, and absence of NA stalk deletion. However, the influence of lower number of glycosites and similarity of the haemadsorbing sites and active centres (sites) between the studied LPAI with HPAI NA N2 protein needs laboratory evaluation. It is also worth to note that the amino acid markers in the M1 protein known to increase the AIV pathogenicity were consistent in ducks and chickens, suggesting the M protein is highly conserved and can serve as a potential universal vaccine across avian species.

Author Contributions

Conceptualization, A.R.M.; writing-original draft preparation, F.A.R. and A.R.M.; writing—review and editing, K.L.H., A.R.O., W.S.T. and M.I.; supervision, A.R.M., W.S.T. and A.R.O.; funding acquisition, A.R.M. and M.I. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by the Ministry of Higher Education (MOHE) through the Fundamental Research Grant Scheme (FRGS/1/2023/STG01/UPM/02/5). The work was also supported by the UK Biotechnology and Biological Sciences Research Council (BBSRC) grants: BBS/E/PI/230002A, BBS/E/PI/230002B, BBS/E/PI/230002C. F.A.R. studentship was funded by the GCRF Networks in Vaccines Research and Development which was co-funded by the MRC and BBSRC and is supported by the IVVN, which was administered by UPM using vote number 6380041.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data are available upon request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Hutchinson, E.C.; Charles, P.D.; Hester, S.S.; Thomas, B.; Trudgian, D.; Martínez-Alonso, M.; Fodor, E. Conserved and host-specific features of influenza virion architecture. Nat. Commun. 2014, 5, 4816. [Google Scholar] [CrossRef] [PubMed]
  2. Kosik, I.; Yewdell, J.W. Influenza hemagglutinin and neuraminidase: Yin-yang proteins coevolving to thwart immunity. Viruses 2019, 11, 346. [Google Scholar] [CrossRef]
  3. Suarez, D.L.; Perdue, M.L.; Cox, N.; Rowe, T.; Bender, C.; Huang, J.; Swayne, D.E. Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong. J. Virol. 1998, 72, 6678–6688. [Google Scholar] [CrossRef] [PubMed]
  4. Abdelwhab, E.-S.M.; Veits, J.; Mettenleiter, T.C. Genetic changes that accompanied shifts of low pathogenic avian influenza viruses toward higher pathogenicity in poultry. Virulence 2013, 4, 441–452. [Google Scholar] [CrossRef]
  5. Dhingra, M.S.; Artois, J.; Dellicour, S.; Lemey, P.; Dauphin, G.; Von Dobschuetz, S.; Van Boeckel, T.P.; Castellan, D.M.; Morzaria, S.; Gilbert, M. Geographical and historical patterns in the emergences of novel highly pathogenic avian influenza (HPAI) H5 and H7 viruses in Poultry. Front. Vet. Sci. 2018, 5, 84. [Google Scholar] [CrossRef] [PubMed]
  6. Hill, N.J.; Bishop, M.A.; Trovão, N.S.; Ineson, K.M.; Schaefer, A.L.; Puryear, W.B.; Zhou, K.; Foss, A.D.; Clark, D.E.; MacKenzie, K.G.; et al. Ecological divergence of wild birds drives avian influenza spillover and global spread. PLoS Pathog. 2022, 18, e1010062. [Google Scholar] [CrossRef] [PubMed]
  7. Kuchipudi, S.V.; Nelli, R.; White, G.A.; Bain, M.; Chang, K.C.; Dunham, S. Differences in influenza virus receptors in chickens and ducks: Implications for interspecies transmission. J. Mol. Genet. Med. 2009, 3, 143–151. [Google Scholar] [CrossRef]
  8. Cornelissen, J.B.; Vervelde, L.; Post, J.; Rebel, J.M. Differences in highly pathogenic avian influenza viral pathogenesis and associated early inflammatory response in chickens and ducks. Avian Pathol. 2013, 42, 347–364. [Google Scholar] [CrossRef]
  9. Nur Adibah, M.; Zailina, H.; Arshad, S.S. Avian influenza outbreaks in Malaysia, 1980–2017. APEOHJ 2017, 3, 1–14. [Google Scholar]
  10. Rasoli, M.; Omar, A.R.; Aini, I.; Jalilian, B.; Syed Hassan, S.H.; Mohamed, M. Fusion of HSP70 gene of Mycobacterium tuberculosis to hemagglutinin (H5) gene of avian influenza virus in DNA vaccine enhances its potency. Acta Virol. 2010, 54, 33–39. [Google Scholar] [CrossRef]
  11. Mariatulqabtiah, A.R.; Majid, N.N.; Giotis, E.S.; Omar, A.R.; Skinner, M.A. Inoculation of fowlpox viruses coexpressing avian influenza H5 and chicken IL-15 cytokine gene stimulates diverse host immune responses. As. Pac. J. Mol. Biol. Biotechnol. 2019, 27, 84–94. [Google Scholar] [CrossRef]
  12. Majid, N.N.; Omar, A.R.; Mariatulqabtiah, A.R. Negligible effect of chicken cytokine IL-12 integration into recombinant fowlpox viruses expressing avian influenza virus neuraminidase N1 on host cellular immune responses. J. Gen. Virol. 2020, 101, 772–777. [Google Scholar] [CrossRef]
  13. Sharifah, S.H.; Suriani, M.N.; Maizan, M.; Ong, G.H.; Azizah, D.; Suzana, K.; Omar, A.R.; Aini, I. Potency and efficacy of a low pathogenic H5N2 inactivated vaccine against challenge with a Malaysian H5N1 highly pathogenic avian influenza virus. J. Vet. Malays. 2013, 25, 1–6. [Google Scholar]
  14. Hoffmann, E.; Stech, J.; Guan, Y.; Webster, R.G.; Perez, D.R. Universal primer set for the full-length amplification of all influenza A viruses. Arch. Virol. 2001, 146, 2275–2289. [Google Scholar] [CrossRef] [PubMed]
  15. Fereidouni, S.R.; Starick, E.; Grund, C.; Globig, A.; Mettenleiter, T.C.; Beer, M.; Harder, T. Rapid molecular subtyping by reverse transcription polymerase chain reaction of the neuraminidase gene of avian influenza A viruses. Vet. Microbiol. 2009, 135, 253–260. [Google Scholar] [CrossRef]
  16. Tamura, K.; Stecher, G.; Kumar, S. Mega11: Molecular evolutionary genetics analysis version 11. Mol. Biol. Evol. 2001, 38, 3022–3027. [Google Scholar] [CrossRef] [PubMed]
  17. Yeo, D.S.-Y.; Ng, S.-H.; Liaw, C.-W.; Ng, L.-M.; Wee, E.J.-H.; Lim, E.A.-S.; Seah, S.L.-K.; Wong, W.-K.; Lim, C.-W.; Sugrue, R.J.; et al. Molecular characterization of low pathogenic avian influenza viruses, isolated from food products imported into Singapore. Vet. Microbiol. 2009, 138, 304–317. [Google Scholar] [CrossRef] [PubMed]
  18. Furuse, Y.; Suzuki, A.; Kamigaki, T.; Oshitani, H. Evolution of the M gene of the influenza A virus in different host species: Large-scale sequence analysis. Virol. J. 2009, 6, 67. [Google Scholar] [CrossRef]
  19. ElHefnawi, M.; AlAidi, O.; Mohamed, N.; Kamar, M.; El-Azab, I.; Zada, S.; Siam, R. Identification of novel conserved functional motifs across most influenza a viral strains. Virol. J. 2011, 8, 44. [Google Scholar] [CrossRef]
  20. Horimoto, T.; Nakayama, K.; Smeekens, S.P.; Kawaoka, Y. Proprotein-processing endoproteases PC6 and furin both activate hemagglutinin of virulent avian influenza viruses. J. Virol. 1994, 68, 6074–6078. [Google Scholar] [CrossRef]
  21. Lang, V.; Rinder, M.; Hafner-Marx, A.; Rabl, S.; Bogner, K.H.; Neubauer-Juric, A.; Büttner, M. Avian Influenza A virus monitoring in wild birds in bavaria: Occurrence and heterogeneity of H5 and N1 encoding genes. Zoonoses Public Health 2010, 57, e184–e194. [Google Scholar] [CrossRef]
  22. Hulse, D.J.; Webster, R.G.; Russell, R.J.; Perez, D.R. Molecular determinants within the surface proteins involved in the pathogenicity of H5N1 influenza viruses in chickens. J. Virol. 2004, 78, 9954–9964. [Google Scholar] [CrossRef]
  23. Webster, R.G.; Kawaoka, Y.; Bean, W.J. Molecular changes in a/chicken/pennsylvania/83 (H5N2) influenza virus associated with acquisition of virulence. Virology 1986, 149, 165–173. [Google Scholar] [CrossRef]
  24. Deshpande, K.L.; Fried, V.A.; Ando, M.; Webster, R.G. Glycosylation affects cleavage of an H5N2 influenza virus hemagglutinin and regulates virulence. Proc. Natl. Acad. Sci. USA 1987, 84, 36–40. [Google Scholar] [CrossRef] [PubMed]
  25. Bender, C.; Hall, H.; Huang, J.; Klimov, A.; Cox, N.; Hay, A.; Gregory, V.; Cameron, K.; Lim, W.; Subbarao, K. Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997–1998. Virology 1999, 254, 115–123. [Google Scholar] [CrossRef]
  26. Munier, S.; Larcher, T.; Cormier-Aline, F.; Soubieux, D.; Su, B.; Guigand, L.; Labrosse, B.; Cherel, Y.; Quéré, P.; Marc, D.; et al. A genetically engineered waterfowl influenza virus with a deletion in the stalk of the neuraminidase has increased virulence for chickens. J. Virol. 2010, 84, 940–952. [Google Scholar] [CrossRef]
  27. Mosaad, Z.; Arafa, A.; Hussein, H.A.; Shalaby, M.A. Mutation signature in neuraminidase gene of avian influenza H9N2/G1 in Egypt. Virusdisease 2017, 28, 164–173. [Google Scholar] [CrossRef]
  28. Xia, J.; Cui, J.-Q.; He, X.; Liu, Y.-Y.; Yao, K.-C.; Cao, S.-J.; Huang, Y. Genetic and antigenic evolution of H9N2 subtype avian influenza virus in domestic chickens in southwestern China, 2013–2016. PLoS ONE 2017, 12, e0171564. [Google Scholar] [CrossRef] [PubMed]
  29. Iqbal, M.; Yaqub, T.; Reddy, K.; McCauley, J.W. Novel genotypes of H9N2 Influenza A viruses isolated from poultry in Pakistan containing NS genes similar to highly pathogenic H7N3 and H5N1 viruses. PLoS ONE 2009, 4, e5788. [Google Scholar] [CrossRef] [PubMed]
  30. Suttie, A.; Deng, Y.-M.; Greenhill, A.R.; Dussart, P.; Horwood, P.F.; Karlsson, E.A. Inventory of molecular markers affecting biological characteristics of avian influenza A viruses. Virus Genes 2019, 55, 739–768. [Google Scholar] [CrossRef] [PubMed]
  31. Nao, N.; Kajihara, M.; Manzoor, R.; Maruyama, J.; Yoshida, R.; Muramatsu, M.; Miyamoto, H.; Igarashi, M.; Eguchi, N.; Sato, M.; et al. A single amino acid in the M1 protein responsible for the different pathogenic potentials of H5N1 highly pathogenic avian influenza virus strains. PLoS ONE 2015, 10, e0137989. [Google Scholar] [CrossRef] [PubMed]
  32. Dong, G.; Peng, C.; Luo, J.; Wang, C.; Han, L.; Wu, B.; Ji, G.; He, H. Adamantane-resistant influenza A viruses in the world (1902–2013): Frequency and distribution of M2 gene mutations. PLoS ONE 2015, 10, e0119115. [Google Scholar] [CrossRef]
  33. Ong, H.K.; Yong, C.Y.; Tan, W.S.; Yeap, S.K.; Omar, A.R.; Razak, M.A.; Ho, K.L. An influenza A vaccine based on the extracellular domain of matrix 2 protein protects BALB/C mice against H1N1 and H3N2. Vaccines 2019, 7, 91. [Google Scholar] [CrossRef] [PubMed]
  34. Ninyio, N.N.; Ho, K.L.; Omar, A.R.; Tan, W.S.; Iqbal, M.; Mariatulqabtiah, A.R. Virus-like particle vaccines: A prospective panacea against an avian influenza panzootic. Vaccines 2020, 8, 694. [Google Scholar] [CrossRef] [PubMed]
  35. Kim, P.; Jang, Y.; Kwon, S.; Lee, C.; Han, G.; Seong, B. Glycosylation of hemagglutinin and neuraminidase of influenza A virus as signature for ecological spillover and adaptation among influenza reservoirs. Viruses 2018, 10, 183. [Google Scholar] [CrossRef] [PubMed]
  36. Hervé, P.-L.; Lorin, V.; Jouvion, G.; Da Costa, B.; Escriou, N. Addition of N-glycosylation sites on the globular head of the H5 hemagglutinin induces the escape of highly pathogenic avian influenza A H5N1 viruses from vaccine-induced immunity. Virology 2015, 486, 134–145. [Google Scholar] [CrossRef]
  37. McAuley, J.L.; Gilbertson, B.P.; Trifkovic, S.; Brown, L.E.; McKimm-Breschkin, J.L. Influenza virus neuraminidase structure and functions. Front. Microbiol. 2019, 10, 39. [Google Scholar] [CrossRef] [PubMed]
  38. Chen, L.; Zhu, F.; Xiong, C.; Zhang, Z.; Jiang, L.; Chen, Y.; Zhao, G.; Jiang, Q. Could a deletion in neuraminidase stalk strengthen human tropism of the novel avian influenza virus H7N9 in China, 2013? Int. J. Environ. Res. Public Health 2015, 12, 1020–1028. [Google Scholar] [CrossRef]
Genes 14 01973 g001
Figure 1. RT-PCR-amplified HA, NA and M genes of the A/Malaysia/Duck/8443/04 H5N2 AIV isolate observed on a 1% (w/v) agarose gel. Lanes 1, 2, and 3 indicate HA, NA, and M genes, respectively. Lanes M: 1 kb DNA ladder marker (Invitrogen). The amplicons corresponded to the expected sizes for HA (1695 bp), NA (1410 bp), and M (1019 bp).
Figure 1. RT-PCR-amplified HA, NA and M genes of the A/Malaysia/Duck/8443/04 H5N2 AIV isolate observed on a 1% (w/v) agarose gel. Lanes 1, 2, and 3 indicate HA, NA, and M genes, respectively. Lanes M: 1 kb DNA ladder marker (Invitrogen). The amplicons corresponded to the expected sizes for HA (1695 bp), NA (1410 bp), and M (1019 bp).
Genes 14 01973 g001
Table 1. Primer sequences used for PCR amplification and verification of the H5N2 genes.
Table 1. Primer sequences used for PCR amplification and verification of the H5N2 genes.
GeneDirectionSequence (5′-3′)Amplicon Size (bp)Reference
HAForwardTATTCGTCTCAGGGAGCAAAAGCAAGGG1733[14]
ReverseATATCGTCTCGTATTAGTAGAAA CAAGGGTGTTTT
NAForwardTATTGGTCTCAGGGAGCAAAAGCA GGAGTAGGAGT1431[14]
ReverseATATGGTCTCGTATTAGTAGAAAC AAGGAGTTTTTT
MForwardTATTCGTCTCAGGGGCAAAAGCAGGTAG1027[14]
ReverseATATCGTCTCGTATTAGTAGAAAC AAGGTAGTTTTT
N2Forward
Reverse		GCATGGTCCAGTTCAAGTTG
CCTTTCCAGTTGTCTCTGCA		362[15]
Table 2. Comparison of the HA cleavage site of several HPAI and LPAI H5 viruses.
Table 2. Comparison of the HA cleavage site of several HPAI and LPAI H5 viruses.
StrainCleavage SiteMolecular CriterionReference
(A/duck/Malaysia/8443/2004(H5N2))PQRE----TRGLLPAIThis study
(A/duck/Japan/9UO036/2009(H5N2))PQRE----TRGLLPAIJX673924.1
(A/duck/Hokkaido/193/04(H5N3))PQRE----TRGLLPAIAB241625.1
(A/migratoryduck/Jiang Xi/13487/2005(H5N3))PQRE----TRGLLPAIEF597260.1
(A/turkey/Italy/1325/2005(H5N2))PQRE----TRGLLPAICY022629.1
(A/duck/Malaysia/F118-08-04/2004(H5N2))PQRE----TRGLLPAIDQ104701.1
(A/duck broiler/Malaysia/F189/07/04(H5N2))PQRE----TRGLLPAIDQ122147.1
(A/mallard/Ohio/11OS2229/2011(H5N2))PQRE----TRGLLPAICY132453.1
(A/duck/New York/483239/2007(H5N2))PQKE----TKGLLPAIGU049935.1
(A/mallard/British Columbia/07826/2005(H5N2))PQRE----TRGLLPAICY047496.1
(A/duck/Hokkaido/W103/2017(H5N2))PQRE----TRGLLPAIMK592509.1
(A/duck/Hebei/0908/2009(H5N2))PQIEGRRRKRGLHPAIJQ041399.1
(A/goose/Guangdong/1/1996(H5N1))PQRERRRKKRGLHPAINC_007362.1
(A/duck/Guangdong/40/2000(H5N1))PQRERRRKKRGLHPAIAY585374.1
(A/duck/Guangxi/53/2002(H5N1))PQRERRRKKRGLHPAIAY585366.1
(A/duck/Guangzhou/20/2005(H5N1))PQRERRRKKRGLHPAIDQ320901.1
(A/duck/Cambodia/D3KP/2006(H5N1))PQRERRRKKRGLHPAIHQ200519.1
(A/duck/Thailand/TS04/2006(H5N1))PQRERRRKKRGLHPAIJQ794470.1
Table 3. HA H5 amino acid sequence comparison at positions known to affect pathogenicity.
Table 3. HA H5 amino acid sequence comparison at positions known to affect pathogenicity.
Virus StrainAmino Acid PositionReference
113124142154228233337–349 (Cleavage Site)
A/duck/Malaysia/8443/2004(H5N2)DTDNSPPQRETR---GLF
(A/duck/Guangzhou/20/2005(H5N1))DIELKSPQRERRRKKRGLF
(A/duck/Thailand/TS04/2006(H5N1))DIELRSPQRERRRKKRGLF
(A/duck/Hebei/0908/2009(H5N2))DIELKSPQIEGRRRKRGLF
A/spotbill duck/Xuyi/18/2005(H5N2)DIENKSPQRERRRKKRGLF
Note: Highlighted rows indicate the HPAI virus strains.
Table 4. Amino acid comparison of predicted glycosites of H5 HA proteins at the globular and stalk domains.
Table 4. Amino acid comparison of predicted glycosites of H5 HA proteins at the globular and stalk domains.
Virus StrainsPotential N-Gly-Position
Globular DomainStalk Domain
39881561701791812092522892627302496500555559
A/duck/Malaysia/8443/2004(H5N2)NVTV----NNTN ---NNSTNSTENSTMNGTY-NGSL-
A/duck/Hebei/0908/2009(H5N2)NVTVNVSE NPSF NSTY NYTN----NNSTNSTENSSM-NGTY-NGSL
A/spotbill duck/Xuyi/18/2005(H5N2)NVTV--NSTY-NNTN---NNSTNSTENSSM-NGTY-NGSL
A/duck/Guangzhou/20/2005(H5N1)NVTV----NNTNNPTT--NNSTNSTENSSM-NGTY-NGSL
A/duck/Thailand/TS04/2006(H5N1)NVTV--NSTY -NNTNNPTT--NNSTNSTENSSM-NGTY-NGSL
Note: Highlighted rows indicate the HPAI virus strains.
Table 5. Amino acid substitutions in the stalk region, haemadsorbing site, and active centre of NA N2 AIV viruses.
Table 5. Amino acid substitutions in the stalk region, haemadsorbing site, and active centre of NA N2 AIV viruses.
VirusDeletion of the Stalk RegionHaemadsorbing SiteActive Centre
366–373399–404431–433140–157
(A/Duck/Malaysia/8443/2004(H5N2))NOISKDSRSGDNSNWSPQELDNKHSNGTIHDRIPHRTL
(A/duck/Hebei/0908/2009(H5N2))NOISKDSRSGDNSNWSPQELNNKHSNGTIHDRIPNRTL
A/spotbill duck/Xuyi/18/2005(H5N2)NOISKDSRSGDNNNWSPQELDNKHSNGTIHDRIPHRTL
(A/chicken/Shandong/S3/2014(H5N2))63–65IKSDLRSGDSESWSPRELKNKHSNGTTHDRIPHRTL
(A/chicken/Hebei/1102-MA/2010(H5N2))63–65IKSDSRSGDSDSWSPQELRNKHSNGTTHDRIPHRTL
Note: Highlighted rows indicate the HPAI virus strains.
Table 6. Sequence of amino acids in glycosites of NA N2 AIV viruses.
Table 6. Sequence of amino acids in glycosites of NA N2 AIV viruses.
Virus StrainPotential N-Gly-Position
616669708386143146155197200231234242261402
(A/Duck/Malaysia/8443/2004(H5N2))NIT-NNT----NGT--NAT-NGT--NWS
(A/duck/Hebei/0908/2009(H5N2))NIT-NNTNTT-NWS-NGTNRT-NAT -NGT--NWS
A/spotbill duck/Xuyi/18/2005(H5N2)NIT-NNTNTT---NGT--NATNGT---NWS
A/chicken/Shandong/S3/2014(H5N2))-NST--NWS-NGT--NAT-NGT-NAS NVS -
(A/chicken/Hebei/1102-MA/2010(H5N2))-NST--NWS-NGT--NAT-NGT--NIS-
Note: Highlighted rows indicate the HPAI virus strains.
Table 7. Molecular markers of AIV M protein linked to virulence and antiviral resistance.
Table 7. Molecular markers of AIV M protein linked to virulence and antiviral resistance.
Virus StrainProtein and the Specific Amino Acid Markers
M1M2
N30DI43MT215AL26FI/V27A/T/SA30V/T/SS31N/GG34E
Increased Virulence in MiceIncreased Virulence in Mice, Chickens, and DucksIncreased Virulence in MiceIncreased Resistance to Amantadine and Rimantadine
A/duck/Malaysia/8443/2004(H5N2)DMALVASG
A/duck/Guangzhou/20/2005(H5N1)DMA-----
A/duck/Thailand/TS04/2006(H5N1)DMALVANG
A/duck/Hebei/0908/2009(H5N2)DMALVASG
A/chicken/Hebei/1102-MA/2010(H5N2))DMALVANG
A/chicken/Shandong/S3/2014(H5N2)DMALVANG
A/chicken/Jiangsu/1001/2013(H5N2)DMALVANG
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Rizal, F.A.; Ho, K.L.; Omar, A.R.; Tan, W.S.; Mariatulqabtiah, A.R.; Iqbal, M. Sequence Analysis of the Malaysian Low Pathogenic Avian Influenza Virus Strain H5N2 from Duck. Genes 2023, 14, 1973. https://doi.org/10.3390/genes14101973

AMA Style

Rizal FA, Ho KL, Omar AR, Tan WS, Mariatulqabtiah AR, Iqbal M. Sequence Analysis of the Malaysian Low Pathogenic Avian Influenza Virus Strain H5N2 from Duck. Genes. 2023; 14(10):1973. https://doi.org/10.3390/genes14101973

Chicago/Turabian Style

Rizal, Fatin Ahmad, Kok Lian Ho, Abdul Rahman Omar, Wen Siang Tan, Abdul Razak Mariatulqabtiah, and Munir Iqbal. 2023. "Sequence Analysis of the Malaysian Low Pathogenic Avian Influenza Virus Strain H5N2 from Duck" Genes 14, no. 10: 1973. https://doi.org/10.3390/genes14101973

APA Style

Rizal, F. A., Ho, K. L., Omar, A. R., Tan, W. S., Mariatulqabtiah, A. R., & Iqbal, M. (2023). Sequence Analysis of the Malaysian Low Pathogenic Avian Influenza Virus Strain H5N2 from Duck. Genes, 14(10), 1973. https://doi.org/10.3390/genes14101973

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop